Kawasaki disease: An evidence based approach to diagnosis, treatment, and proposals for future research

Archives of Disease in Childhood

Volumn 86, Issue 4, 2002, Pages 286-290

  Brogan, P A ^a   Dillon, M J ^a   Bose, A ^b   Burgner, D ^c   Shingadia, D ^b   Tulloh, R ^d   Michie, C ^e   Klein, N ^c   Booy, R ^b   Levin, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e EALING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; DIPYRIDAMOLE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; VACCINE;

ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONJUNCTIVITIS; CORONARY ARTERY ANEURYSM; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FEVER; HUMAN; ISCHEMIC HEART DISEASE; LYMPHADENOPATHY; META ANALYSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; UNITED KINGDOM;

ADRENAL CORTEX HORMONES; ASPIRIN; HEART DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MUCOCUTANEOUS LYMPH NODE SYNDROME; RESEARCH; VACCINATION;

EID: 0036221798     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.86.4.286     Document Type: Article

References (29)

1. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Clinical observation of 50 patients
2. Kawasaki disease
3. Recognition and management of Kawasaki disease
4. Kawasaki disease: Recent advances
5. Kawasaki disease in families
6. T cells recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease
7. Vasculitis
8. Comparison of low dose aspirin (LDA) vs. high dose aspirin (HDA) as an adjunct to intravenous gamma globulin (IVIG) in the treatment of Kawasaki syndrome (KS)
9. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose
10. Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease
11. The prevention of coronary artery aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobin treatment
12. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease
13. Kawasaki disease: Effect of treatment on coronary artery involvement
14. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids
15. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin
16. Interference of immune globulin with measles and rubella immunization
17. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin
18. Management of Kawasaki disease in the British Isles
19. Sequelae of Kawasaki disease in adolescents and young adults
20. Kawasaki disease. Current treatment options
21. Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy
22. Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease
23. Evidence for a superantigen mediated process in Kawasaki disease
24. Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease
25. Kawasaki syndrome (KS) is not caused by toxic shock syndrome toxin-1 (TSST1) + staphylococci
26. Animal models of infection-mediated vasculitis: Implications for human disease
27. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant
28. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: Findings from brain and renal microvascular cell culture and patients with active disease